CD274 and cancer: Despite the extraordinary effectiveness of blocking the immune checkpoint PD1-PDL1 in the curative therapy of several tumors, the majority of cancer patients were unable to react satisfactorily to immunotherapy (Mounika et al., 2023[84]).